IQV Iqvia Holdings Inc

Price (delayed)

$240.84

Market cap

$43.71B

P/E Ratio

32.59

Dividend/share

N/A

EPS

$7.39

Enterprise value

$56.23B

IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development ...

Highlights
The price to earnings (P/E) is 61% lower than the 5-year quarterly average of 82.3 and 6% lower than the last 4 quarters average of 34.2
IQV's EPS is up by 27% year-on-year and by 22% since the previous quarter
Iqvia Holdings's debt has increased by 7% YoY

Key stats

What are the main financial stats of IQV
Market
Shares outstanding
181.5M
Market cap
$43.71B
Enterprise value
$56.23B
Valuations
Price to book (P/B)
7.19
Price to sales (P/S)
2.95
EV/EBIT
26.39
EV/EBITDA
17.27
EV/Sales
3.75
Earnings
Revenue
$14.98B
EBIT
$2.13B
EBITDA
$3.26B
Free cash flow
$1.5B
Per share
EPS
$7.39
Free cash flow per share
$8.16
Book value per share
$33.49
Revenue per share
$81.52
TBVPS
$39.58
Balance sheet
Total assets
$26.68B
Total liabilities
$20.57B
Debt
$13.9B
Equity
$6.11B
Working capital
-$895M
Liquidity
Debt to equity
2.27
Current ratio
0.86
Quick ratio
0.75
Net debt/EBITDA
3.85
Margins
EBITDA margin
21.7%
Gross margin
35%
Net margin
9.1%
Operating margin
13.2%
Efficiency
Return on assets
5.2%
Return on equity
23%
Return on invested capital
16.6%
Return on capital employed
10.6%
Return on sales
14.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

IQV stock price

How has the Iqvia Holdings stock price performed over time
Intraday
0.93%
1 week
5.98%
1 month
-4.58%
1 year
18.65%
YTD
4.09%
QTD
-4.76%

Financial performance

How have Iqvia Holdings's revenue and profit performed over time
Revenue
$14.98B
Gross profit
$5.24B
Operating income
$1.98B
Net income
$1.36B
Gross margin
35%
Net margin
9.1%
Iqvia Holdings's net income has increased by 24% YoY and by 22% QoQ
Iqvia Holdings's net margin has increased by 21% from the previous quarter and by 20% YoY
IQV's operating income is up by 10% year-on-year and by 7% since the previous quarter
Iqvia Holdings's operating margin has increased by 6% QoQ and by 6% YoY

Growth

What is Iqvia Holdings's growth rate over time

Valuation

What is Iqvia Holdings stock price valuation
P/E
32.59
P/B
7.19
P/S
2.95
EV/EBIT
26.39
EV/EBITDA
17.27
EV/Sales
3.75
The price to earnings (P/E) is 61% lower than the 5-year quarterly average of 82.3 and 6% lower than the last 4 quarters average of 34.2
IQV's EPS is up by 27% year-on-year and by 22% since the previous quarter
The stock's price to book (P/B) is 13% more than its 5-year quarterly average of 6.3 and 6% more than its last 4 quarters average of 6.7
The equity has grown by 6% YoY and by 5% from the previous quarter
The stock's price to sales (P/S) is 9% more than its last 4 quarters average of 2.7 and 4.6% more than its 5-year quarterly average of 2.8
IQV's revenue is up by 4% YoY

Efficiency

How efficient is Iqvia Holdings business performance
IQV's return on assets is up by 21% since the previous quarter and by 18% year-on-year
The ROE has increased by 20% QoQ and by 18% YoY
The company's return on invested capital rose by 20% YoY and by 6% QoQ
IQV's return on sales is up by 15% year-on-year and by 6% since the previous quarter

Dividends

What is IQV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IQV.

Financial health

How did Iqvia Holdings financials performed over time
The total assets is 30% greater than the total liabilities
Iqvia Holdings's current ratio has increased by 9% from the previous quarter but it has decreased by 3.4% YoY
The quick ratio has increased by 9% QoQ
Iqvia Holdings's debt is 127% more than its equity
Iqvia Holdings's debt has increased by 7% YoY
The equity has grown by 6% YoY and by 5% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.